Abstract:The blood-brain barrier (BBB) is considered as the primary impediment barrier for most drugs. Delivering therapeutic agents to the brain is still a big challenge to date. In our study, a dual mechanism, receptor mediation combined with external non-invasive magnetic force, was incorporated into ferrous magnet-based liposomes for BBB transmigration enhancement. The homogenous magnetic nanoparticles (MNPs), with a size of similar to 10 nm, were synthesized and confirmed by TEM and XRD respectively. The classical magnetism assay showed the presence of the characteristic superparamagnetic property. These MNPs encapsulated in PEGylated fluorescent liposomes as magneto-liposomes (MLs) showed mono-dispersion, similar to 130 +/- 10 nm diameter, by dynamic laser scattering (DLS) using the lipid-extrusion technique. Remarkably, a magnetite encapsulation efficiency of nearly 60% was achieved. Moreover, the luminescence and hydrodynamic size of the MLs was stable for over two months at 4 degrees C. Additionally, the integrity of the ML structure remained unaffected through 120 rounds of circulation mimicking human blood fluid. After biocompatibility confirmation by cytotoxicity evaluation, these fluorescent MLs were further embedded with transferrin and applied to an in vitro BBB transmigration study in the presence or absence of external magnetic force. Comparing with magnetic force-or transferrin receptor-mediated transportation alone, their synergy resulted in 50-100% increased transmigration without affecting the BBB integrity. Consequently, confocal microscopy and iron concentration in BBB-composed cells further confirmed the higher cellular uptake of ML particles due to the synergic effect. Thus, our multifunctional liposomal magnetic nanocarriers possess great potential in particle transmigration across the BBB and may have a bright future in drug delivery to the brain.

Enhanced Blood-Brain Barrier Transmigration Using a Novel Transferrin Embedded Fluorescent Magneto-Liposome Nanoformulation.

Transferrin-conjugated, fluorescein-loaded magnetic nanoparticles for targeted delivery across the blood–brain barrier

Development and characterization of lipid nanocapsules loaded with iron oxide nanoparticles for magnetic targeting to the blood–brain barrier

Transferrin-conjugated magnetic dextran-spermine nanoparticles for targeted drug transport across blood-brain barrier

The blood-brain barrier penetration and distribution of PEGylated fluorescein-doped magnetic silica nanoparticles in rat brain.

Receptor-mediated delivery of magnetic nanoparticles across the blood-brain barrier.

Blood-Brain Barrier Transport of Transferrin Receptor-Targeted Nanoparticles

Construction of Multifunctonal Nano-delivery System Crossing Blood Brain Barrier

Micro‐Nanocarriers Based Drug Delivery Technology for Blood‐Brain Barrier Crossing and Brain Tumor Targeting Therapy (small 45/2022)

Synthetic Polymer Nanoparticles Functionalized with Different Ligands for Receptor-mediated Transcytosis Across Blood-Brain Barrier.

Advancing Central Nervous System Drug Delivery with Microtubule-Dependent Transcytosis of Novel Aqueous Compounds

Nanotechnology Driven Lipid and Metalloid Based Formulations Targeting Blood–Brain Barrier (3B) for Brain Tumor

Nanocarriers for Magnetically Actuated Targeted Drug Delivery

Transactivating-Transduction Protein-Polyethylene Glycol Modified Liposomes Traverse the Blood-Spinal Cord and Blood-Brain Barriers

Nanocarrier Drug Release and Blood-Brain Barrier Penetration at Post-Stroke Microthrombi Monitored by Real-Time F&oumlrster Resonance Energy Transfer-Based Detection System (FedEcs)

Receptor-Assisted Nanotherapeutics for Overcoming the Blood–Brain Barrier

Hybrid stem cell-derived bioresponsive vesicles for effective inflamed blood-brain barrier targeting delivery

Strategies for transporting nanoparticles across the blood-brain barrier.

Development of L-carnosine functionalized iron oxide nanoparticles loaded with dexamethasone for simultaneous therapeutic potential of blood brain barrier crossing and ischemic stroke treatment

A Dual-Mediated Liposomal Drug Delivery System Targeting the Brain: Rational Construction, Integrity Evaluation Across the Blood-Brain Barrier, and the Transporting Mechanism to Glioma Cells

Liposomes and Lipid Disks Traverse the BBB and BBTB As Intact Forms As Revealed by Two-Step Förster Resonance Energy Transfer Imaging